- Home
- INDO vs ICCC Comparison
INDO vs ICCC Comparison
Compare INDO & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- ICCC
- Stock Information
- Founded
- INDO 2018
- ICCC 1982
- Country
- INDO Indonesia
- ICCC United States
- Employees
- INDO N/A
- ICCC N/A
- Industry
- INDO Oil & Gas Production
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- INDO Energy
- ICCC Health Care
- Exchange
- INDO Nasdaq
- ICCC Nasdaq
- Market Cap
- INDO 40.1M
- ICCC 45.9M
- IPO Year
- INDO 2019
- ICCC 1987
- Fundamental
- Price
- INDO $3.10
- ICCC $5.50
- Analyst Decision
- INDO
- ICCC
- Analyst Count
- INDO 0
- ICCC 0
- Target Price
- INDO N/A
- ICCC N/A
- AVG Volume (30 Days)
- INDO 805.1K
- ICCC 10.0K
- Earning Date
- INDO 10-25-2024
- ICCC 02-25-2025
- Dividend Yield
- INDO N/A
- ICCC N/A
- EPS Growth
- INDO N/A
- ICCC N/A
- EPS
- INDO N/A
- ICCC N/A
- Revenue
- INDO $3,127,587.00
- ICCC $23,838,001.00
- Revenue This Year
- INDO N/A
- ICCC N/A
- Revenue Next Year
- INDO N/A
- ICCC N/A
- P/E Ratio
- INDO N/A
- ICCC N/A
- Revenue Growth
- INDO N/A
- ICCC 46.37
- 52 Week Low
- INDO $2.03
- ICCC $3.34
- 52 Week High
- INDO $6.65
- ICCC $5.82
- Technical
- Relative Strength Index (RSI)
- INDO 51.50
- ICCC 62.66
- Support Level
- INDO $2.92
- ICCC $4.86
- Resistance Level
- INDO $3.31
- ICCC $5.50
- Average True Range (ATR)
- INDO 0.30
- ICCC 0.35
- MACD
- INDO 0.02
- ICCC -0.01
- Stochastic Oscillator
- INDO 45.36
- ICCC 100.00
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.